Chapter 60

Reference

  1. Abuodeh RO, Shubitz LF, Siegel E, et al. 1999. Resistance to Coccidioides immitis in mice after immunization with recombinant protein or DNA vaccine of a proline-rich antigen. Infect Immun 67:2935-2940.
  2. Ampel NM. 2009. Coccidioidomycosis: a review of recent advances. Clin Chest Med 30:241-251.
  3. Angel JA, Shively JN, Merideth RE, et al. 1985. Ocular coccidiomycosis in a cat. J Am Vet Med Assoc 187:167-169.
  4. Anstead GM, Corcoran G, Lewis J, et al. 2005. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis 40:1770-1776.
  5. Antony S. 2004. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient. Clin Infect Dis 39:879-880.
  6. Antony S, Dominguez DC, Sotelo E. 2003. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis. J Natl Med Assoc 95:982-985.
  7. Barsanti JA, Jeffery KL. 1990. Coccidioidomycosis, pp 687-695. In Greene CE (ed): Infectious diseases of the dog and cat, ed 1. WB Saunders, Philadelphia.
  8. Bartsch R, Greene R. 1997. New treatment of coccidioidomycosis. Vet Forum Apr:50-52.
  9. Blalek R, Kern J, Herrmann T, et al. 2004. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/praline-rich antigen. J Clin Microbiol 42:778-783.
  10. Braverman IM. 1998. Protective effects of erythema nodosum in coccidioidomycosis. Lancet 353:168.
  11. Brilhante RS, Cordeiro RA, Rocha MF. 2008. Coccidioidal pericarditis: a rapid presumptive diagnosis by an in-house antigen confirmed by mycological and molecular methods. J Med Microbiol 57:1288-1292.
  12. Burkiewicz CD, Shubitz LF, Dial SM. 2005. Risk factors associated with Coccidioides infection in dogs. J Am Vet Med Assoc 226:1851-1854.
  13. Burtch M. 1998. Granulomatous meningitis caused by Coccidioides immitis in a dog. J Am Vet Med Assoc 212:827-829.
  14. 13a. Canteros CE, Madariaga MJ, Lee W, et al. 2010. [Agentes de micosis endemicas en un area rural de Argentina: studio seroepidemiologico en perros.] Rev Iberoam Micol 27:14-19.
  15. Casal JI, Alvarez RO, Lee W, et al. 2008. Disseminated coccidioidomycosis in a dog. Rev Argent De Microbiol 40:109.
  16. Catanzaro A, Cloud G, Stevens D, et al. 2000. Safety and tolerance of posaconazole (SCH 56592) in patients with non-meningeal disseminated coccidioidomycosis, abstract no 1417. From the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy, September 17-20, Toronto, Ontario, Canada.
  17. Catanzaro A, Cloud GA, Stevens DA, et al. 2007. Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis. Clin Infect Dis 45:562-568.
  18. Catanzaro A, Galgiani JN, Levine BE, et al. 1995. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. Am J Med 98:249-256.
  19. Cha JM, Jung S, Bahng HS, et al. 2000. Multi-organ failure caused by reactivated coccidioidomycosis without dissemination in a patient with renal transplantation. Espirology 5:87-90.
  20. Charlton V, Ramsdell K, Sehring S. 1999. Intrauterine transmission of coccidioidomycosis. Pediatr Infect Dis J 18:561-562.
  21. Chaturvedi V, Ramani R, Gromadzki S, et al. 2000. Coccidioidomycosis in New York state. Emerg Infect Dis 6:25-29.
  22. Chiller TM, Galgiani JN, Stevens DA. 2003. Coccidioidomycosis. Infect Dis Clin North Am 17:41-57.
  23. 21a. Clemons KV, Capilla J, Stevens DA. 2009. Experimental animal models of coccidioidomycosis. Ann N Y Acad Sci 1111:208-224.
  24. Clemons KV, Howell, KJ, Calderon L, et al. 2000. Efficacy of intravenous AmBisome against coccidioidal meningitis in rabbits, abstract no 2120. From the 40th Interscience Conference of Antimicrobial Agents and Chemotherapy, September 17-20, Toronto, Ontario, Canada.
  25. Clemons KV, Sobel RA, Williams PL, et al. 2002. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrobial Agents Chemother 46:2420-2426.
  26. Clemons KV, Stevens DA. 1997. Efficacies of two novel azole derivatives, each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis. Antimicrob Agents Chemother 41:200-203.
  27. Cole GT, Hung CY, Delgado N. 2002. Parasitic phase-specific gene expression in Coccidioides. ASM News 68:603-611.
  28. Cortez KJ, Walsh TJ, Bennett JE. 2003. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis 36:1619-1622.
  29. Cox RA, Magee DM. 2004. Coccidioidomycosis: host response and vaccine development. Clin Microbiol Rev 17:804-839.
  30. Crabtree AC, Keith DG, Diamond HL. 2008. Relationship between radiographic hilar lymphadenopathy and serologic titers for Coccidioides sp. in dogs in an endemic region. Vet Radiol Ultrasound 49:501-503.
  31. deAguiar R, Brilhante RS, Rocha MF, et al. 2007. Rapid diagnosis of coccidioidomycosis by nested PCR assay of sputum. Clin Microbiol Infect 13:449-451.
  32. Deresinski S. 2003. Coccidioides immitis as a potential bioweapon. Semin Respir Infect 18:216-219.
  33. Durkin M, Connolly P, Kuberski T, et al. 2008. Diagnosis of coccidioidomycosis with use of the Coccidioides antigen enzyme immunoassay. Clin Infect Dis 47:67-73.
  34. 31a. Engelthaler DM, Chiller T, Schupp JA, et al. 2011. Next-generation sequencing of Coccicioides immitis isolated during cluster investigation. Emerg Infect Dis 17:227-232.
  35. Erly WK, Bellon RJ, Seeger JF, et al. 1999. MR imaging of acute coccidioidal meningitis. Am J Neuroradiol 20:509-514.
  36. Fierer J, Walls L, Eckmann L, et al. 1998. Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis. Infect Immun 66:4397-4402.
  37. Fisher MC, Koenig GL, White TJ, et al. 2002. Molecular and phenotypic description of Coccidioides posadasii sp nov., previously recognized as the non-California population of Coccidioides immitis. Mycologica 94:73-84.
  38. 34a. Fontana FF, Barbosa dos Santos CT, et al. 2010. Seroepidemiological survey of paracoccidioidomycosis infection among urban and rural dogs from Uberaba Minas Gerais, Brazil. Mycopathol 169:159-165.
  39. Foureman P, Longshore R, Plummer SB. 2005. Spinal cord granuloma due to Coccidioides immitis in a cat. J Vet Intern Med 19:373-376.
  40. Gade W, Ledman DW, Wethington R, et al. 1992. Serological responses to various Coccidioides antigen preparations in a new enzyme immunoassay. J Clin Microbiol 30:1907-1912.
  41. Gaidici A, Saubolle MA. 2009. Transmission of coccidioidomycosis to a human via a cat bite. J Clin Microbiol 47:505-506.
  42. Galgiani, JN. 1999. Coccidioidomycosis: a regional disease of national importance: rethinking approaches for control. Ann Intern Med 130:293-300.
  43. Galgiani JN, Ampel NM, Catanzaro A, et al. 2000. Practice guidelines for the treatment of coccidioidomycosis. Clin Infect Dis 30:658-661.
  44. Galgiani JN, Catanzaro A, Cloud GA, et al. 2000. Comparison of oral fluconazole and itraconazole for progressive, non-meningeal coccidioidomycosis: a randomized, double-blind trial. Ann Intern Med 133:676-686.
  45. Galgiani JN, Dugger KO, Ito JI, et al. 1984. Antigenemia in primary coccidioidomycosis. Am J Trop Med Hyg 33:645-649.
  46. González GM, González G, Najvar LK, et al. 2007. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model. J Antimicrob Chemother 60:1341-1346.
  47. Gonzalez GM, Tijerina R, Najvar LK, et al. 2001. Correlation between antifungal susceptibilities of Coccidioides immitis in-vitro and antifungal treatment with caspofungin in a mouse model. Antimicrob Agents Chemother 45:1854-1859.
  48. Gonzalez GM, Tijerina R, Najvar, LK, et al. 2002. In-vitro and in-vivo activities of posaconazole against Coccidioides immitis. Antimicrob Agents Chemother 46:1352-1356.
  49. González, GM, Tijerina, R, Sutton, DA, et al. 2002. In vitro activities of free and lipid formulations of amphotericin B and nystatin against clinical isolates of Coccidioides immitis at various saprobic stages. Antimicrobial Agents Chemother 46:1583-1585.
  50. 45a. Gonzalez JF, Montiel NA, Maass RL. 2010. First report on the diagnosis and treatment of encephalic and urinary paracoccidioidomycosis in a cat. J Feline Med Surg 12:659-662.
  51. Graupmann-Kuzma A, Valentine BA, Shubitz LF, et al. 2008. Coccidioidomycosis in dogs and cats: a review. J Am Anim Hosp Assoc 44:226-235.
  52. Graybill JR, Stevens DA, Galgiani JN, et al. 1990. Itraconazole treatment of coccidioidomycosis. Am J Med 89:282-290.
  53. Greene DR, Koenig G, Fisher MC, et al. 2000. Soil isolation and molecular identification of Coccidioides immitis. Mycologia 92:406-410.
  54. Greene RT. 2003. Personal observation. Phoenix Veterinary IM Services, Phoenix.
  55. Greene RT, Troy GC. 1995. Coccidioidomycosis in 48 cats: a retrospective study (1984-1993). J Vet Intern Med 9:86-91.
  56. Hagman HM, Madnick EG, D’Agostino AN, et al. 2000. Hyphal forms in the central nervous system of patients with coccidioidomycosis. Clin Infect Dis 30:349-355.
  57. Hector RF, Laniado-Laborin R. 2005. Coccidioidomycosis—a fungal disease of the Americas. PLoS Med 2:15-18.
  58. Hector RF, Zimmer BL, Pappagianis D. 1990. Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis. Antimicrob Agents Chemother 34:587-593.
  59. Heinritz CK, Gilson SD, Soderstrom MJ, et al. 2005. Subtotal pericardectomy and epicardial excision for treatment of coccidioidomycosis-induced effusive-constrictive pericarditis in dogs: 17 cases (1999-2003). J Am Vet Med Assoc 227:435-440.
  60. Hirschmann JV. 2007. The early history of coccidioidomycosis: 1892-1945. Clin Infect Dis 44:1202-1207.
  61. Hsue G, Napier JT, Prince RA, et al. 2004. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother 54:292-294.
  62. Jeroski A. 2003. Multicentric lymphoma and disseminated coccidioidomycosis in a dog. Can Vet J 44:62-64.
  63. Jiang C, Magee DM, Quitugua TN, et al. 1999. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA. Infect Immun 67:630-635.
  64. Johnson LR, Herrgesell EJ, Davidson AP, et al. 2003. Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995-2000). J Am Vet Med Assoc 222:461-466.
  65. Kauffman CA, Wiseman SW. 1998. Anaphylaxis upon switching lipid-containing amphotericin B formulations. Clin Infect Dis 26:1237-1238.
  66. Kim A, Parker SS. 2002. Coccidioidomycosis: case report and update on diagnosis and management. J Am Acad Dermatol 46:743-747.
  67. Kim K, Leung AN, Flint JDA, et al. 1998. Chronic pulmonary coccidioidomycosis: computed tomographic and pathologic findings in 18 patients. Can Assoc Radiol J 49:401-407.
  68. Kirkland TN, Fierer J. 1996. Coccidioidomycosis: a re-emerging infectious disease. Emerging Infect Dis 2:192-199.
  69. Koehler AP, Cheng AFB, Chu KC, et al. 1998. Successful treatment of disseminated coccidioidomycosis with amphotericin B lipid complex. J Infect Dis 36:113-115.
  70. Kohn GJ, Linne SR, Smith CM, et al. 1992. Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis 15:527-530.
  71. Kuberski TT, Servi RJ, Rubin PJ. 2004. Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma. Clin Infect Dis 38:910-912.
  72. Lutz JE, Clemons KV, Aristizabal BH, et al. 1997. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis. Antimicrob Agents Chemother 41:1558-1561.
  73. Martins TB, Jaskowski TD, Mouritsen CL, et al. 1995. Comparison of commercially available enzyme immunoassay with traditional serological tests for detection of antibodies to Coccidioides immitis. J Clin Microbiol 33:940-943.
  74. Meyer PR, Hui AN, Biddle M. 1982. Coccidioides immitis meningitis with arthroconidia in cerebrospinal fluid: report of the first case and review of the arthroconidia literature. Hum Pathol 13:1136-1138.
  75. Mirels LF, Stevens DA. 1997. Update on treatment of coccidioidomycosis. West J Med 166:58-59.
  76. Mos Edo N, Netto CF. 1974. Contribution to the study of paracoccidioidomycosis. I. Possible epidemiological role of dogs. Serological and anatomo/pathological study. Rev Inst Med Trop Sao Paulo 16:154-159.
  77. Mos Edo N, Netto CF, Saliba AM, et al. 1974. Contribution to the study of paracoccidioidomycosis. II. Experimental infection of dogs. Rev Inst Med Trop Sao Paulo 16:232-237.
  78. Muñoz-Hernández B, Martínez-Rivera MA, Palma Cortés G, et al. 2008. Mycelial forms of Coccidioides spp in the parasitic phase associated to pulmonary coccidioidomycosis with type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 27:813-820.
  79. Nielsen C, Sutton DA, Matise I, et al. 2005. Isolation of Cokeromyces recurvatus, initially misidentified as Coccidioides immitis, from peritoneal fluid in a cat with jejunal perforation. J Vet Diagn Invest 17:372-278.
  80. Oldfield EC, Bone WD, Martin CR, et al. 1997. Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis 25:1205-1210.
  81. Ono MA, Kishima MO, Itano EN, et al. 2003. Experimental paracoccidioidomycosis in dogs. Med Mycol 41:265-268.
  82. Ophulus W. 1905. Further observations on a pathogenic mould formerly described as a protozoan (Coccidioides immitis: Coccidioides pyogenes). J Exp Med 6:443-485.
  83. Orsborn KI, Galgiani JN. 1998. Detecting serum antibodies to a purified recombinant proline-rich antigen of Coccidioides immitis in patients with coccidioidomycosis. Clin Infect Dis 27:1475-1478.
  84. Pappagianis D & the Valley Fever Vaccine Study Group. 1993. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 148:656-660.
  85. Pappagianis D, Hector R, Levine HB, et al. 1979. Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect Immun 25:440-445.
  86. Pappagianis D, Zimmer BL. 1990. Serology of coccidioidomycosis. Clin Microbiol Rev 3:247-268.
  87. Plotnick AN, Boshoven EW, Rosychuk RA. 1997. Primary cutaneous coccidioidomycosis and subsequent drug eruption to itraconazole in a dog. J Am Anim Hosp Assoc 33:139-143.
  88. Prabhu RM, Bonnell M, Currier BL, et al. 2004. Successful treatment of disseminated non meningeal coccidioidomycosis with voriconazole. Clin Infect Dis 39:74-77.
  89. Proia LA, Tenorio AR. 2004. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother 48:2341.
  90. Reed RE. 1958. Canine coccidioidomycosis. SW Vet 12:26-32.
  91. Ricci G, Mota FT, Wakamatsu A, et al. 2004. Canine paracoccidioidomycosis. Med Mycol 42:379-383.
  92. Richards JO, Ampel NM, Lake DF. 2002. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis. J Immunol 169:2020-2025.
  93. Rippon JW (ed). 1988. Medical mycology: the pathogenic fungi and the pathogenic Actinomycetes, ed 3. WB Saunders, Philadelphia.
  94. Rubensohn M, Stack S. 2003. Coccidiomycosis in a dog. Can Vet J 44:159-160.
  95. Sarosi GA, Lawrence JP, Smith DK, et al. 2001. Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis. Semin Respir Infect 16:238-241.
  96. Schneider E, Hajjeh RA, Spiegel RA, et al. 1997. A coccidioidomycosis outbreak following the Northridge California earthquake. J Am Med Assoc 277:904-908.
  97. Sekhon AS, Issac-Renton J, Dixon JM, et al. 1991. Review of human and animal cases of coccidioidomycosis diagnosed in Canada. Mycopathologia 113:1-10.
  98. 92a. Shubitz LF. 2007. Comparative aspects of coccidioidomycosis in animals and humans. Ann N Y Acad Sci 1111:395-403.
  99. Shubitz LF, Butkiewicz DD, Dial SM, et al. 2005. Incidence of Coccidioides infection among dogs residing in a region in which the organism is endemic. J Am Vet Med Assoc 226:1846-1850.
  100. Shubitz LF, Dial SM. 2005. Coccidioidomycosis: a diagnostic challenge. Curr Tech Small Anim Pract 20:220-226.
  101. Shubitz LF, Dial SM, Perill R, et al. 2008. Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii. Infect Immun 76:5553-5564.
  102. Shubitz L, Peng T, Perrill R, et al. 2002. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA. Infect Immun 70:3287-3289.
  103. Shubitz LF, Matz ME, Noon TH, et al. 2001. Constrictive pericarditis secondary to Coccidioides immitis infection in a dog. J Am Vet Med Assoc 218:537-540.
  104. Sinke JD, Sjollema BE. 1994. Coccidioidomycosis in a dog. Vet Q 16(Suppl 1):64S.
  105. Stevens DA. 1995. Coccidioidomycosis. N Engl J Med 332:1077-1082.
  106. Stevens DA. 1997. Editorial response: adequacy of therapy for coccidioidomycosis. Clin Infect Dis 25:1211-1212.
  107. Stevens DA, Shatsky SA. 2001. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect 16:263-269.
  108. 101a. Tofflemire K, Betbeze C. 2010. Three cases of feline ocular coccidioidomycosis : presentation, clinical features, diagnosis and treatment. Vet Ophthalmol 13:166-172.
  109. Tucker RM, Denning DW, Arathoon EG, et al. 1990. Itraconazole therapy for non-meningeal coccidioidomycosis: clinical and laboratory observations. J Am Acad Dermatol 23:593-601.
  110. Zepeda MR, Kobayashi GK, Appleman MD, et al. 1998. Coccidioides immitis presenting as a hyphal form in cerebrospinal fluid. J Natl Med Assoc 90:435-436.
  111. Zimmermann CR, Johnson SM, Martens GW, et al. 1998. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Infect Immun 66:2342-2345.